Member Exclusive News

The week in industry: Collaboration to develop first human-specific in vitro model of heart failure

This week: US FDA grants priority review for FGFR inhibitor for bile duct cancer, new drug approval to slow rate of pulmonary decline in systemic sclerosis patients and US$20 million for the launch of patient-partnered rare disease drug repurposing program.

Go to the profile of RxNet
Nov 28, 2019
0
0

Please sign in or register for FREE

No comments yet.